Expression of vascular endothelial growth factor receptor-2, epidermal growth factor receptor, cyclooxygenase-2, survivin, E-cadherin and Ki-67 in canine nasal carcinomas and sarcomas – a pilot study
Based on similarities in marker expression between canine carcinomas and sarcomas, clinical studies should further elucidate the use of TKI or COX-2 inhibitors as additional therapy in dogs with nasal sarcomas.
Authors
- Johannes Junginger (ORCID: https://orcid.org/0000-0002-4965-4553)
- Gerhard Oechtering (ORCID: https://orcid.org/0000-0002-2597-3234)
- Sarah Rösch (ORCID: https://orcid.org/0000-0003-0420-963X)
- Marion Hewicker‐Trautwein (ORCID: https://orcid.org/0000-0002-4278-331X)
- Ljuba Anna Maria Pauly
Institutions
- University of Veterinary Medicine Hannover, Foundation (DE)
- Leipzig University (DE)
Publication Details
- Journal
- Frontiers in Veterinary Science
- Published
- 2024-08-29
- DOI
- https://doi.org/10.3389/fvets.2024.1388493
- Citations
- 4
- Primary Topic
- Veterinary Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.68